Now I have all the material I need. Let me compose the comprehensive nursing exam notes.
π UNIT IV: IMMUNITY, HYPERSENSITIVITY & IMMUNIZATION
Complete Nursing Exam-Ready Notes
1. INTRODUCTION
- The human body is constantly exposed to harmful microorganisms (bacteria, viruses, fungi, parasites).
- The body has a defense system called the immune system to fight these threats.
- This unit covers how immunity works, what happens when it overreacts (hypersensitivity), and how we use vaccines to protect people.
2. DEFINITION
| Term | Definition |
|---|
| Immunity | The body's ability to resist infection and disease caused by foreign substances |
| Antigen | Any foreign substance that triggers an immune response (e.g., bacteria, virus, pollen) |
| Antibody | A protective protein made by B cells in response to an antigen |
| Immunization | The process of making a person immune to a disease, usually by a vaccine |
| Hypersensitivity | An exaggerated immune response that damages the body's own tissues |
3. TYPES / CLASSIFICATION OF IMMUNITY
A. Basic Classification
IMMUNITY
βββ INNATE (Natural / Non-Specific)
β βββ Present from birth
β βββ No memory
β βββ First line of defense
βββ ADAPTIVE (Acquired / Specific)
βββ Develops after exposure
βββ Has MEMORY
βββ Specific to each antigen
B. Innate Immunity β Details
| Component | Function |
|---|
| Skin & mucus membranes | Physical barrier |
| Stomach acid (pH 2) | Kills pathogens |
| Fever | Slows pathogen growth |
| Inflammation | Brings WBCs to site of infection |
| NK cells (Natural Killer cells) | Kill virus-infected & cancer cells |
| Phagocytes (neutrophils, macrophages) | Engulf and destroy pathogens |
| Complement system | Proteins that lyse (burst) bacteria |
| Interferons | Antiviral proteins released by infected cells |
C. Adaptive Immunity β Details
Two branches:
ADAPTIVE IMMUNITY
βββ HUMORAL (B-cell mediated)
β βββ B lymphocytes β plasma cells β ANTIBODIES
β βββ Fights extracellular pathogens (bacteria, viruses in blood)
β βββ Example: antibodies against Tetanus toxin
βββ CELL-MEDIATED (T-cell mediated)
βββ T lymphocytes (T-helper, T-cytotoxic)
βββ Fights intracellular pathogens (viruses, TB, fungi)
βββ Example: killing of virus-infected cells by CD8+ T cells
D. Classification by How Immunity Is Acquired
ACQUIRED IMMUNITY
βββ ACTIVE (host makes own antibodies)
β βββ Natural Active β infection/disease (e.g., chicken pox)
β βββ Artificial Active β VACCINES (e.g., MMR vaccine)
βββ PASSIVE (ready-made antibodies given)
βββ Natural Passive β maternal antibodies via placenta/breast milk
βββ Artificial Passive β antiserum/immunoglobulins (e.g., anti-rabies serum)
Mnemonic: NAPA β Natural Active, Passive Active β think "NAPA" for the four types
| Feature | Active | Passive |
|---|
| Antibody source | Host makes own | Transferred from outside |
| Onset | Slow (days-weeks) | Immediate |
| Duration | Long-lasting (years/life) | Short (weeks-months) |
| Memory | YES | NO |
| Example | Vaccine, natural infection | Anti-tetanus serum, breast milk |
4. ANTIGEN AND ANTIBODY REACTION
What is an Antigen?
- A substance (usually protein or polysaccharide) that the immune system recognizes as foreign
- Has special sites called epitopes (antigenic determinants) β these are the parts the antibody binds to
- Types:
- T-dependent antigen β needs T-helper cells to stimulate antibody production (most proteins)
- T-independent antigen β stimulates B cells directly (polysaccharides)
What is an Antibody (Immunoglobulin)?
- A Y-shaped glycoprotein made by plasma cells (activated B cells)
- Specifically binds to the antigen that triggered its production
Antigen-Antibody Reaction (Immunological Reaction)
Antigen enters body
β
Recognized by B cells (with help from T-helper cells)
β
B cells β Plasma cells β Antibodies produced
β
Antibody binds to specific antigen (lock-and-key)
β
Results in:
βββ Neutralization (toxin/virus rendered harmless)
βββ Opsonization (antigen coated for phagocytosis)
βββ Complement activation (bacterial lysis)
βββ Agglutination (clumping of antigens)
βββ Precipitation (soluble antigen made insoluble)
5. IMMUNOGLOBULINS: STRUCTURE, TYPES & PROPERTIES
Structure of an Antibody (IgG as model)
Fab (Antigen-binding) Fab
ββββββββββ ββββββββββ
β VH+VL β β VH+VL β β Variable regions (bind antigen)
ββββββ¬ββββ ββββββ¬ββββ
β β
ββββββ΄βββββββββββββββββ΄βββββ
β HINGE REGION β β Flexible
β CH2 β
β CH3 β β Fc region (complement, receptor binding)
ββββββββββββββββββββββββββββ
- 2 Heavy chains (H) + 2 Light chains (L) linked by disulfide bonds
- Each chain has a Variable region (V) β binds antigen (unique per antibody)
- Each chain has a Constant region (C) β determines Ig class and effector function
- Fab fragment = antigen-binding fragment (contains variable regions)
- Fc fragment = crystallizable fragment (binds complement, macrophage receptors)
- Paratope = part of antibody that binds to epitope
Five Classes of Immunoglobulins
| Class | % in serum | Structure | Key Properties |
|---|
| IgG | 75β80% | Monomer | Most abundant; crosses placenta (passive immunity to newborn); 4 subclasses (IgG1β4); secondary immune response; opsonization |
| IgA | 10β15% | Dimer (secretory) | Found in secretions: saliva, tears, breast milk, intestinal mucus; first defense at mucosal surfaces |
| IgM | 5β10% | Pentamer | Largest Ig; first to appear in primary immune response; best at agglutination & complement activation; ABO blood group antibodies |
| IgE | Trace (<0.01%) | Monomer | Allergic reactions (binds mast cells, basophils); anti-parasitic immunity; involved in Type I hypersensitivity |
| IgD | <1% | Monomer | B-cell surface receptor; function not fully known |
Mnemonic: GAMED β IgG, IgA, IgM, IgE, IgD (in order of serum concentration)
Properties Summary Table
| Property | IgG | IgA | IgM | IgE | IgD |
|---|
| Crosses placenta | β
| β | β | β | β |
| In secretions | β | β
| β | β | β |
| Complement fixation | β
| β | β
β
| β | β |
| Allergy/anaphylaxis | β | β | β | β
| β |
| Primary response | β | β | β
| β | β |
6. HYPERSENSITIVITY REACTIONS
Definition
- An exaggerated or inappropriate immune response to an antigen (allergen) that causes tissue damage
- Classified by Gell and Coombs (1963) into 4 types
Gell & Coombs Classification
HYPERSENSITIVITY
βββ Type I β Immediate / Anaphylactic (IgE-mediated)
βββ Type II β Cytotoxic (IgG/IgM-mediated, cell destruction)
βββ Type III β Immune Complex (IgG-mediated, complex deposition)
βββ Type IV β Delayed / Cell-mediated (T-cell mediated, NO antibody)
Mnemonic: ACID β Anaphylactic, Cytotoxic, Immune-complex, Delayed
TYPE I β Immediate Hypersensitivity (Anaphylactic)
Mediator: IgE
Time of onset: Within minutes (15β30 min)
Cells involved: Mast cells, basophils, eosinophils
Mechanism (Flowchart):
First exposure to allergen (e.g., peanut, penicillin, pollen)
β
B cells stimulated β IgE antibodies produced
β
IgE binds to surface of MAST CELLS and BASOPHILS (sensitization)
β
Second exposure to same allergen
β
Allergen cross-links IgE on mast cells
β
DEGRANULATION β release of:
βββ Histamine β vasodilation, bronchoconstriction, itching
βββ Leukotrienes β prolonged bronchoconstriction
βββ Prostaglandins β inflammation
βββ Tryptase (marker of anaphylaxis)
β
Clinical effects: urticaria, angioedema, bronchospasm, anaphylaxis
Examples:
- Anaphylaxis (penicillin, bee sting)
- Bronchial asthma
- Allergic rhinitis (hay fever)
- Urticaria (hives)
- Food allergy (peanuts, shellfish)
Clinical Example:
A 22-year-old nursing student receives IV penicillin and within 10 minutes develops rash, swelling of throat, low BP, and difficulty breathing β Anaphylactic shock = Type I hypersensitivity. Treatment: Adrenaline (epinephrine) 0.5 mg IM immediately.
TYPE II β Cytotoxic Hypersensitivity
Mediator: IgG or IgM
Time of onset: Minutes to hours
Target: Cell surface antigens (host cells destroyed)
Mechanism:
Antibody (IgG/IgM) binds to antigen on HOST CELL SURFACE
β
Complement activated β cell LYSIS (MAC attack)
OR
Phagocytosis of opsonized cells
OR
ADCC (Antibody Dependent Cell-mediated Cytotoxicity)
β
HOST CELLS DESTROYED
Examples:
- ABO transfusion reactions (wrong blood group given)
- Hemolytic disease of newborn (Rh incompatibility β Rhβve mother, Rh+ve baby)
- Autoimmune hemolytic anemia
- Goodpasture syndrome (antibodies to glomerular basement membrane)
- Myasthenia gravis (antibodies against acetylcholine receptors)
- Graves' disease (antibodies stimulate TSH receptors β hyperthyroidism)
TYPE III β Immune Complex Hypersensitivity
Mediator: IgG (or IgM) antigen-antibody complexes
Time of onset: Hours (3β10 hours)
Target: Blood vessels, kidneys, joints (where complexes deposit)
Mechanism:
Antigen (soluble) + Antibody β IMMUNE COMPLEX formed
β
Immune complexes DEPOSIT in vessel walls, glomeruli, joints
β
Complement activated
β
Neutrophils attracted β release lysosomal enzymes
β
TISSUE INFLAMMATION and DAMAGE
Examples:
- Serum sickness (after horse antiserum β old anti-tetanus)
- Post-streptococcal glomerulonephritis
- Systemic Lupus Erythematosus (SLE)
- Rheumatoid arthritis
- Arthus reaction (local immune complex reaction β repeat injection)
- Farmer's lung (inhaled mold antigens)
TYPE IV β Delayed-Type Hypersensitivity (Cell-Mediated)
Mediator: T lymphocytes (NO antibody, NO complement)
Time of onset: 48β72 hours (delayed)
Cells: CD4+ T-helper cells (Th1), CD8+ cytotoxic T cells, macrophages
Mechanism:
First exposure to antigen β T cells sensitized (memory T cells formed)
β
Second exposure (24β72 hrs later)
β
Memory T cells recognize antigen via APC (dendritic cells/macrophages)
β
T cells activated β release CYTOKINES (IFN-Ξ³, TNF, IL-2)
β
Macrophages activated β release inflammatory mediators
β
TISSUE DESTRUCTION (granuloma formation)
Examples:
- Tuberculin (Mantoux) test β most important exam example
- Contact dermatitis (nickel, latex, poison ivy)
- Graft rejection (transplant rejection)
- Granulomatous diseases (TB, leprosy, sarcoidosis)
Clinical Example:
A nurse reads a Mantoux test 72 hours after injection. She finds induration [hardness] of 15 mm β Positive β suggests TB infection = Type IV hypersensitivity
Comparison Table of All 4 Types
| Feature | Type I | Type II | Type III | Type IV |
|---|
| Mediator | IgE | IgG/IgM | IgG/IgM complexes | T cells |
| Onset | Min (< 30 min) | Minβhours | 3β10 hrs | 48β72 hrs |
| Complement | β | β
| β
| β |
| Cells | Mast cells, basophils | Complement, phagocytes | Neutrophils | T cells, macrophages |
| Key example | Anaphylaxis | ABO mismatch | SLE, serum sickness | Mantoux, contact dermatitis |
| Transferred by | Serum (IgE) | Serum | Serum | Cells only |
7. SEROLOGICAL TESTS (Antigen-Antibody Tests)
Serology [sero = serum] = laboratory tests that detect antibodies or antigens in blood serum
Classification of Serological Tests
A. Precipitation Tests
- Antigen + Antibody β insoluble precipitate forms
- Examples:
- Immunodiffusion (Ouchterlony test) β antigens/antibodies diffuse in gel; precipitation line forms where they meet
- VDRL test (Venereal Disease Research Laboratory) β for syphilis screening; flocculation [clumping] reaction
- RPR test (Rapid Plasma Reagin) β syphilis
- C-reactive protein (CRP) test β detects inflammation
B. Agglutination Tests
- Antigen (cell surface) + Antibody β visible clumping
- Examples:
- Widal test β for typhoid fever (detects antibodies against Salmonella typhi)
- ABO blood grouping β agglutination of RBCs
- Coombs test (DCT/ICT) β hemolytic disease of newborn, autoimmune hemolytic anemia
- ASO test (Anti-Streptolysin O) β detects recent streptococcal infection
- RA Factor (Rheumatoid Factor) test β for rheumatoid arthritis
C. Complement Fixation Tests
- If antigen + antibody present β complement is "used up" (fixed) β indicator system remains intact (no lysis)
- Examples:
- Wassermann test β syphilis (historical)
- CFT for viral antibodies β measles, mumps
D. Neutralization Tests
- Antibody neutralizes the biological activity of a toxin or virus
- Examples:
- ASO titre β neutralization of streptolysin O
- Virus neutralization tests β check immunity to specific viruses
E. Immunofluorescence Tests
- Antibodies labeled with fluorescent dye β seen under fluorescence microscope
- Examples:
- IFAT (Indirect Fluorescent Antibody Test)
- ANA test (Anti-Nuclear Antibody) β for SLE
- TPHA test β for syphilis confirmation
F. Enzyme-Linked Tests (ELISA)
- ELISA (Enzyme-Linked ImmunoSorbent Assay)
- Most common and important modern test
- Detects antibodies (IgG, IgM) or antigens
- Used for:
- HIV screening (ELISA for anti-HIV antibodies)
- Hepatitis B & C
- TORCH infections in pregnancy
- COVID-19 antibody tests
G. Radioimmunoassay (RIA)
- Uses radioactively labeled antigen or antibody
- Very sensitive but requires radioactive material
- Used for: hormone levels (insulin, TSH), HBsAg (Hepatitis B surface antigen)
H. Western Blot
- Confirmatory test for HIV (after ELISA screening)
- Separates viral proteins by electrophoresis β detected by antibodies
- Gold standard for HIV confirmation
Important Serological Tests Summary Table
| Test | Disease | Principle |
|---|
| Widal test | Typhoid | Agglutination |
| VDRL / RPR | Syphilis | Precipitation/Flocculation |
| ASO titre | Streptococcal infection | Neutralization/Agglutination |
| Coombs test (DCT/ICT) | Hemolytic anemia, Rh incompatibility | Agglutination |
| ELISA | HIV, Hepatitis, COVID-19 | Enzyme-linked |
| Western Blot | HIV confirmation | Immunoelectrophoresis |
| ANA test | SLE | Immunofluorescence |
| Mantoux/Tuberculin | TB | Delayed hypersensitivity (Type IV) |
| RA Factor | Rheumatoid arthritis | Agglutination |
8. VACCINES: TYPES, CLASSIFICATION, STORAGE & COLD CHAIN
Definition
- A vaccine is a biological preparation that provides active acquired immunity to a specific disease
- It contains antigens (weakened/killed/toxoid/subunit) that stimulate an immune response without causing disease
Types / Classification of Vaccines
1. Live Attenuated [weakened] Vaccines
- Contain weakened but living microorganisms
- Give strong, long-lasting immunity (similar to natural infection)
- Usually 1β2 doses sufficient
- Contraindicated in immunocompromised patients (HIV, on steroids)
| Vaccine | Disease |
|---|
| BCG | Tuberculosis |
| OPV (Oral Polio Vaccine) | Poliomyelitis |
| MMR | Measles, Mumps, Rubella |
| Varicella vaccine | Chickenpox |
| Yellow Fever vaccine | Yellow fever |
| Rotavirus vaccine | Rotavirus diarrhea |
| Typhoid oral (Ty21a) | Typhoid |
2. Killed (Inactivated) Vaccines
- Contain dead microorganisms β cannot cause disease
- Safer, more stable
- Require multiple doses + boosters (weaker immunity)
- Safe in immunocompromised patients
| Vaccine | Disease |
|---|
| IPV (Inactivated Polio Vaccine) | Poliomyelitis |
| Pertussis (whole cell) in DPT | Whooping cough |
| Rabies vaccine (HDCV) | Rabies |
| Influenza (injectable) | Influenza |
| Cholera vaccine | Cholera |
| Hepatitis A vaccine | Hepatitis A |
3. Toxoid Vaccines
- Made from inactivated bacterial toxins (the poison, not the bacteria)
- Stimulate antibodies against toxin only
- Very stable
| Vaccine | Disease |
|---|
| DT / dT / Td | Diphtheria, Tetanus |
| TT (Tetanus Toxoid) | Tetanus |
4. Subunit / Recombinant Vaccines
- Contain only specific parts (proteins) of the pathogen
- Very safe, no risk of infection
- Hepatitis B vaccine (HBsAg protein) β recombinant DNA technology
- Pertussis acellular (DTaP) β pertussis proteins only
- HPV vaccine (Gardasil, Cervarix) β virus-like particles
- Pneumococcal vaccine (PCV)
- Meningococcal vaccine
5. Conjugate Vaccines
- Polysaccharide antigen conjugated (joined) to a protein carrier
- Makes polysaccharide antigens work in infants (T-cell dependent response)
- Examples:
- Hib vaccine (Haemophilus influenzae type b)
- PCV (Pneumococcal Conjugate Vaccine)
- MenACWY (Meningococcal conjugate vaccine)
6. mRNA Vaccines (Newer type)
- Deliver instructions (mRNA) for cells to make viral protein β immune response
- Example: COVID-19 vaccines (Pfizer-BioNTech, Moderna)
- No DNA alteration; mRNA quickly degraded
7. Combination Vaccines
- Multiple vaccines in one injection
- Reduces number of injections, increases compliance
| Vaccine | Diseases covered |
|---|
| DPT (Diphtheria-Pertussis-Tetanus) | Diphtheria, Whooping cough, Tetanus |
| MMR | Measles, Mumps, Rubella |
| MMRV | Measles, Mumps, Rubella, Varicella |
| Pentavalent vaccine | Diphtheria, Tetanus, Pertussis, Hepatitis B, Hib |
| Hexavalent vaccine | + Polio |
Vaccine Storage and Handling
Principles
- Vaccines are biological products β destroyed by heat, freezing (some), and light
- Must be stored at correct temperature throughout supply chain
Storage Temperatures
| Vaccine Category | Storage Temp |
|---|
| Freeze-sensitive (must NOT freeze) | +2Β°C to +8Β°C (refrigerator) |
| Freeze-tolerant (can freeze) | β15Β°C to β25Β°C (freezer) |
| Vaccine | Storage | Sensitivity |
|---|
| BCG | Freezer (β15Β°C to β25Β°C) | Sensitive to heat & light |
| OPV | Freezer (β20Β°C) | Very heat-sensitive; can store frozen |
| IPV | Refrigerator (+2 to +8Β°C) | Freeze-sensitive |
| DPT | Refrigerator (+2 to +8Β°C) | FREEZE-SENSITIVE β freezing destroys it |
| Hepatitis B | Refrigerator (+2 to +8Β°C) | FREEZE-SENSITIVE |
| TT | Refrigerator (+2 to +8Β°C) | FREEZE-SENSITIVE |
| MMR | Freezer or refrigerator | Sensitive to heat & light |
| Measles | Refrigerator, protect from light | Heat & light-sensitive |
| Pentavalent | Refrigerator (+2 to +8Β°C) | FREEZE-SENSITIVE |
β οΈ Key exam point: Vaccines most sensitive to freezing: DPT, TT, Hepatitis B, IPV, Pentavalent
β οΈ Vaccines most sensitive to heat: OPV, BCG, Measles, MMR
Reconstituted Vaccines (mixed before use)
- BCG, Measles, MMR must be used within 4β6 hours after reconstitution [mixing with diluent]
- Discard unused reconstituted vaccine at end of session
Cold Chain
Definition
- Cold chain = the system of transporting and storing vaccines at the correct temperature from manufacturer to patient
Importance
- Maintains potency (effectiveness) of vaccines
- Prevents vaccine wastage
- Ensures immunization programs succeed
Cold Chain Equipment
VACCINE MANUFACTURER (β25Β°C to β15Β°C or +2 to +8Β°C)
β
PRIMARY VACCINE STORE (National level) β Deep freezers + ILR
β
REGIONAL / STATE VACCINE STORE β Deep freezers + ILR
β
DISTRICT VACCINE STORE β ILR (Ice-Lined Refrigerator) + Deep freezers
β
PHC (Primary Health Center) β ILR + Deep freezers
β
SUBCENTRE / SESSION SITE β Vaccine carrier + cold packs
β
PATIENT / COMMUNITY
Equipment Abbreviations:
- ILR = Ice-Lined Refrigerator (insulated box, runs on electricity, stores +2 to +8Β°C)
- Deep Freezer = stores at β15Β°C to β25Β°C (for OPV, BCG)
- Vaccine carrier = insulated box with frozen ice packs β for transport to field
- Cold box = large insulated box for transport between stores
- Cold packs / Ice packs = keep vaccines cold in carrier
Cold Chain Monitoring Tools
| Tool | Purpose |
|---|
| VVM (Vaccine Vial Monitor) | Sticker on vaccine vial β changes color if vaccine exposed to excess heat; tells if vaccine is unusable |
| Thermometer | Measures fridge/freezer temperature |
| Freeze indicator (FI) | Detects if freeze-sensitive vaccine was frozen |
| Electronic data logger | Continuous temperature recording |
| Open Vial Policy | Allows reuse of unopened multi-dose vials at next session (except BCG, measles, yellow fever, VZV) |
VVM Reading (Exam Important)
VVM (inner square inside outer circle)
βββ Inner square LIGHTER than outer circle β USABLE β
βββ Inner square SAME or DARKER than outer circle β DISCARD β
Nursing Responsibilities in Cold Chain
- Check temperature daily (2 times/day: morning and evening) β record in temperature log
- Never store food, blood, or other items in vaccine fridge
- Never keep vaccines in door of refrigerator (temperature fluctuates)
- Place ice packs at bottom of vaccine carrier before use
- Check VVM before giving each vaccine
- Report cold chain equipment failures immediately
- Store vaccines according to FIFO (First In, First Out) principle
- Keep extra ice packs in freezer always
9. IMMUNIZATION FOR VARIOUS DISEASES β NATIONAL IMMUNIZATION SCHEDULE (India)
Universal Immunization Programme (UIP)
- Started in India in 1985 (expanded from EPI started 1978)
- Mission Indradhanush launched 2014 β aimed to increase coverage to 90%+ children
- Target: Pregnant women + children 0β5 years
Immunization Schedule (India β Current UIP)
| Age | Vaccine | Route | Dose | Site |
|---|
| Birth (0β24 hrs) | OPV-0 (birth dose) | Oral | 2 drops | Mouth |
| BCG | Intradermal | 0.05 ml (<1 yr), 0.1 ml (>1 yr) | Left upper arm |
| Hepatitis B (birth dose) | IM | 0.5 ml | Anterolateral thigh (right) |
| 6 weeks (1.5 months) | OPV-1 | Oral | 2 drops | Mouth |
| Pentavalent-1 (DPT+HepB+Hib) | IM | 0.5 ml | Anterolateral thigh (left) |
| Rotavirus-1 | Oral | 5 drops | Mouth |
| PCV-1 (Pneumococcal) | IM | 0.5 ml | Anterolateral thigh (right) |
| fIPV-1 (Fractional IPV) | Intradermal | 0.1 ml | Right anterolateral thigh |
| 10 weeks (2.5 months) | OPV-2 | Oral | 2 drops | |
| Pentavalent-2 | IM | 0.5 ml | |
| Rotavirus-2 | Oral | 5 drops | |
| 14 weeks (3.5 months) | OPV-3 | Oral | 2 drops | |
| Pentavalent-3 | IM | 0.5 ml | |
| Rotavirus-3 | Oral | 5 drops | |
| PCV-2 | IM | 0.5 ml | |
| fIPV-2 | Intradermal | 0.1 ml | |
| 9β12 months | Measles-Rubella (MR)-1 | Subcutaneous | 0.5 ml | Right upper arm |
| PCV Booster | IM | 0.5 ml | |
| Vitamin A (1st dose) | Oral | 1 lakh IU | |
| 16β24 months | DPT Booster-1 | IM | 0.5 ml | Anterolateral thigh |
| OPV Booster | Oral | 2 drops | |
| MR-2 | Subcutaneous | 0.5 ml | Right upper arm |
| Vitamin A (every 6 months till 5 yrs) | Oral | 2 lakh IU | |
| 5β6 years | DPT Booster-2 | IM | 0.5 ml | Upper arm |
| 10 years & 16 years | Td (Tetanus + adult diphtheria) | IM | 0.5 ml | Upper arm |
Vaccines for Pregnant Women
| Vaccine | Schedule | Purpose |
|---|
| TT/Td-1 | As early as possible in pregnancy | Sensitization dose |
| TT/Td-2 | 4 weeks after TT-1 | Boosts immunity |
| TT Booster | If received TT in last 3 years | Single booster dose |
Protection conferred: Prevents neonatal tetanus (tetanus in newborn) and maternal tetanus
Other Important Vaccines (Optional/Special Situations)
| Vaccine | For Whom | Schedule |
|---|
| Typhoid vaccine | Age 2 yrs+; endemic areas, travellers | Oral (Ty21a): 3 doses; IM (Vi): 1 dose; booster every 3 years |
| Hepatitis A vaccine | Age 1 yr+; not in UIP | 2 doses: 0 and 6β12 months |
| Varicella (Chickenpox) | 12 months+; 2 doses | 0 and 3 months |
| HPV vaccine | Girls 9β14 yrs (cervical cancer prevention) | 2 doses: 0 and 6 months |
| Meningococcal | High-risk, Hajj pilgrims | Single dose |
| Yellow Fever | Travellers to endemic areas (Africa, S. America) | 1 dose; life-long protection |
| Rabies (post-exposure) | After animal bite | Days 0, 3, 7, 14, 28 (IM) |
| Japanese Encephalitis (JE) | Endemic districts in India | 2 doses at 9 months and 16β24 months |
| Influenza | Healthcare workers, elderly, high-risk | Annual dose |
| Pneumococcal (PPSV23) | Adults >65 yrs, immunocompromised | 1β2 doses |
10. NURSING CARE IN IMMUNIZATION
Pre-vaccination Nursing Responsibilities
- Take detailed history: previous vaccinations, allergies, current illness
- Contraindications to check:
- Acute febrile illness β postpone vaccine
- Anaphylaxis to previous dose β contraindicated
- Live vaccines in immunocompromised patients
- Encephalopathy within 7 days of DPT β no more DPT
- Inform parents about the vaccine, disease it prevents, and possible side effects (consent)
- Check VVM on each vaccine vial
- Check expiry date
- Prepare correct dose and reconstitute if needed
- Check cold chain maintenance
During Vaccination
- Use correct route (IM, SC, intradermal, oral)
- Use correct site as per age
- Use proper injection technique (no air bubbles for injections)
- Observe strict aseptic technique
- Dispose of needles safely (no recapping β sharps container)
- Reconstituted vaccine: shake well before use
Post-vaccination Nursing Responsibilities
- Observe patient for 30 minutes for anaphylaxis (especially after first dose)
- Anaphylaxis kit ready: adrenaline, antihistamine, corticosteroids, IV fluids
- Document: vaccine name, dose, batch number, expiry, site, date
- Inform parents about normal post-vaccination reactions
- Advice for common side effects:
- Fever β paracetamol, tepid sponging
- Local swelling/redness β cold compress, reassurance
- BCG ulcer/scar β normal, no treatment needed
- OPV: sore mouth β very rare; reassure
AEFI (Adverse Events Following Immunization)
-
Any untoward medical event that follows immunization
-
Types:
- Vaccine-related (e.g., VAPP β vaccine-associated paralytic polio from OPV)
- Injection-related (abscess, nerve damage)
- Immunization error (wrong dose, wrong route)
- Coincidental (not caused by vaccine)
-
Must be reported to health authorities within 24 hours for serious AEFI
11. SIGNS & SYMPTOMS β ANAPHYLAXIS (most important acute immune emergency)
Anaphylaxis = severe, life-threatening Type I hypersensitivity reaction
Mnemonic: "ABCDEF" for Anaphylaxis features
- Airway obstruction (throat swelling, stridor)
- Breathing difficulty (bronchospasm, wheeze)
- Cardiovascular collapse (hypotension, tachycardia)
- Dermal signs (urticaria, angioedema, flushing, itching)
- Excretion (nausea, vomiting, diarrhea)
- Feeling of doom (anxiety, confusion, loss of consciousness)
Anaphylaxis Management (Nursing Emergency)
RECOGNIZE: Symptoms within minutes of exposure
β
CALL FOR HELP / CODE BLUE
β
LAY PATIENT FLAT β raise legs (unless breathing difficulty β semi-recumbent)
β
ADRENALINE (EPINEPHRINE): 0.5 mg IM (1:1000) in outer thigh β FIRST DRUG
β
Oβ therapy (high flow, 10β15 L/min via mask)
β
IV access β normal saline bolus (500 mlβ1 L)
β
ANTIHISTAMINE: Chlorphenamine 10 mg IV/IM
β
HYDROCORTISONE: 200 mg IV (prevents biphasic reaction)
β
MONITOR: BP, pulse, SpOβ every 5 min
β
OBSERVE minimum 6 hours (risk of biphasic reaction β second wave)
12. DIAGNOSIS / INVESTIGATIONS FOR IMMUNE DISORDERS
| Investigation | Purpose |
|---|
| CBC with differential | WBC count; lymphocytopenia β immunodeficiency |
| Serum immunoglobulins (IgG, IgA, IgM, IgE) | Low IgG β hypogammaglobulinemia; high IgE β allergy |
| Skin prick test / intradermal test | Detects Type I hypersensitivity (allergy testing) |
| Patch test | Detects Type IV (contact dermatitis) |
| Mantoux test | Detects TB (Type IV hypersensitivity) |
| ELISA | HIV, Hepatitis, autoantibodies |
| ANA (Anti-Nuclear Antibody) | SLE |
| Complement levels (C3, C4) | Low in SLE, immune complex diseases |
| Flow cytometry | CD4/CD8 count (HIV staging) |
| Western Blot | HIV confirmation |
| Coombs test | Hemolytic anemia |
13. COMPLICATIONS
Complications of Immune Disorders
| Condition | Complication |
|---|
| Anaphylaxis | Death from cardiovascular/respiratory collapse |
| Hypersensitivity reactions | Organ damage, chronic inflammation |
| SLE | Lupus nephritis, pericarditis, neuropsychiatric lupus |
| Rheumatoid arthritis | Joint deformity, disability |
Complications of Vaccines
| Vaccine | Complication |
|---|
| OPV | VAPP (Vaccine-Associated Paralytic Polio) β rare, 1/750,000 |
| BCG | BCG-itis (disseminated BCG in immunocompromised) |
| DPT | Febrile seizures, encephalopathy (rare) |
| MMR | Febrile seizures, thrombocytopenia (rare) |
Complications of Cold Chain Failure
- Vaccine rendered ineffective (loss of potency)
- Vaccine-preventable disease outbreaks
- False sense of security in immunized population
14. PREVENTION
- Maintain cold chain rigorously
- Educate communities about immunization benefits
- Ensure complete immunization schedule is followed (full doses, correct timing)
- Monitor for AEFI and report
- Conduct immunization camps in remote areas (Mission Indradhanush)
- Administer vaccines by trained healthcare personnel only
- Maintain herd immunity [when enough population is immune, disease cannot spread]
15. QUICK REVISION POINTS β‘
- Innate = non-specific, fast, no memory | Adaptive = specific, slower, has memory
- Active immunity = makes own antibodies (long lasting) | Passive = ready-made antibodies (short lasting)
- IgG = most abundant, crosses placenta | IgA = secretions/mucosa | IgM = first in primary response | IgE = allergy/anaphylaxis
- Type I = IgE, mast cells, immediate β anaphylaxis, asthma, urticaria
- Type II = IgG/IgM, cell destruction β ABO mismatch, hemolytic disease of newborn
- Type III = immune complexes β SLE, serum sickness, post-strep GN
- Type IV = T cells, 48β72 hrs β Mantoux test, contact dermatitis, graft rejection
- VDRL = syphilis | Widal = typhoid | ELISA = HIV, Hep B | Western Blot = HIV confirmation
- VVM inner square lighter than outer = vaccine usable β
| Same/darker = discard β
- DPT, TT, HepB = freeze-sensitive | OPV, BCG = heat-sensitive
- First drug in anaphylaxis = ADRENALINE (Epinephrine) 0.5 mg IM
- BCG given at birth (0β24 hrs) | OPV birth dose also at birth
- Pentavalent = 5 antigens in 1 vaccine: DPT + HepB + Hib
- Observe 30 minutes post-vaccination for anaphylaxis
16. MICROBIOLOGY β RELEVANT POINTS
Immunological Aspects of Microbiology
Bacterial vaccines: Made from killed bacteria (cholera), toxoids (DPT), or live attenuated (BCG)
Viral vaccines: Live attenuated (OPV, MMR, BCG) or killed (IPV, rabies)
Serological diagnosis of infections:
- Typhoid: Widal test (H & O agglutinins β₯ 1:160 = significant)
- Syphilis: VDRL (screening) β TPHA or FTA-ABS (confirmation)
- HIV: ELISA (screening) β Western blot (confirmation)
- Hepatitis B: HBsAg (surface antigen) = active infection; Anti-HBs = immunity
17. PHARMACOLOGY β RELEVANT DRUGS
Drugs Used in Anaphylaxis
| Drug | Class | Mechanism | Dose | Nursing Points |
|---|
| Epinephrine (Adrenaline) | Alpha + Beta agonist | Bronchodilates, raises BP, reverses vasodilation | 0.5 mg IM (1:1000) | FIRST DRUG; IM in outer thigh; can repeat after 5 min |
| Chlorphenamine (Piriton) | H1-antihistamine | Blocks histamine H1 receptors β reduces itch, urticaria | 10 mg IV/IM | Causes drowsiness; do not drive |
| Hydrocortisone | Corticosteroid | Anti-inflammatory; prevents late/biphasic reaction | 200 mg IV | Not first-line; supports long-term control |
| Salbutamol | Beta-2 agonist | Bronchodilation | Nebulized | For persistent bronchospasm |
Drugs Used in Hypersensitivity (Allergy)
| Drug | Use |
|---|
| Cetirizine, Loratadine (2nd gen antihistamines) | Allergic rhinitis, urticaria β less sedating |
| Montelukast (Leukotriene receptor antagonist) | Asthma, allergic rhinitis |
| Prednisolone (oral corticosteroid) | Severe allergy, autoimmune disease |
| Omalizumab (Anti-IgE antibody) | Severe allergic asthma β reduces free IgE |
18. CLINICAL EXAMPLES
Case 1: Anaphylaxis
A 30-year-old woman receives IV amoxicillin for UTI. Within 5 minutes she develops generalized urticaria, throat tightness, wheezing, and BP drops to 70/40 mmHg.
Diagnosis: Anaphylaxis β Type I hypersensitivity to penicillin
Immediate nursing action: Stop drug β Call help β Lay flat β Adrenaline 0.5 mg IM β Oβ β IV fluids
Case 2: Mantoux (Tuberculin) Test
A 20-year-old nurse undergoes a Mantoux test. At 72 hours, she has induration [raised hardness] of 18 mm.
Interpretation: Positive (β₯10 mm in healthcare workers = significant)
Type: Type IV (Delayed) Hypersensitivity
Next step: Chest X-ray + sputum AFB smear to rule out active TB
π EXAMINATION QUESTIONS
LONG QUESTIONS (10β15 marks each)
- Classify immunity. Describe innate and adaptive immunity in detail with differences.
- Describe the structure and classes of immunoglobulins. Add a note on their properties and functions.
- Classify and explain hypersensitivity reactions with pathophysiology, clinical examples, and nursing management.
- Describe the cold chain system in immunization. What are cold chain equipment, monitoring tools, and nursing responsibilities in maintaining cold chain?
- Write the national immunization schedule for children under 5 years. Add a note on vaccines for pregnant women and AEFI.
SHORT QUESTIONS (5 marks each)
- Write a note on Type I (anaphylactic) hypersensitivity β mechanism and management.
- Differentiate between active and passive immunity with examples.
- Explain the Gell and Coombs classification of hypersensitivity reactions.
- What is the Vaccine Vial Monitor (VVM)? How is it used?
- Write a short note on serological tests used in clinical practice.
VERY SHORT QUESTIONS (2 marks each)
- Define antigen and antibody.
- What is an epitope?
- Which immunoglobulin crosses the placenta?
- Name the immunoglobulin involved in allergic reactions.
- What is the first drug given in anaphylaxis?
- What is herd immunity?
- Define cold chain.
- What is AEFI? Give one example.
- State two freeze-sensitive vaccines.
- What is the route and dose of BCG vaccine?
MULTIPLE CHOICE QUESTIONS (MCQs)
1. Which immunoglobulin is the FIRST to appear in a primary immune response?
a) IgG b) IgA c) IgM β
d) IgE
2. Type IV hypersensitivity is mediated by:
a) IgE b) IgG c) Complement d) T lymphocytes β
3. The Mantoux test is an example of which type of hypersensitivity?
a) Type I b) Type II c) Type III d) Type IV β
4. Which vaccine is most sensitive to HEAT?
a) DPT b) TT c) OPV β
d) Hepatitis B
5. Anaphylaxis is treated FIRST with:
a) Hydrocortisone b) Chlorphenamine c) Adrenaline β
d) Salbutamol
6. IgA is mainly found in:
a) Blood only b) Secretions (saliva, tears, breast milk) β
c) Lymph nodes d) Bone marrow
7. Which vaccine is given INTRADERMALLY?
a) DPT b) Hepatitis B c) BCG β
d) OPV
8. VVM inner square is DARKER than outer circle. The nurse should:
a) Use the vaccine b) Keep in freezer c) Discard the vaccine β
d) Warm the vaccine
9. Serum sickness is an example of which hypersensitivity?
a) Type I b) Type II c) Type III β
d) Type IV
10. The pentavalent vaccine protects against how many diseases?
a) 3 b) 4 c) 5 β
d) 6
(Diphtheria, Pertussis, Tetanus, Hepatitis B, Hib)
ANSWER KEY
| Q | Answer |
|---|
| MCQ 1 | c β IgM |
| MCQ 2 | d β T lymphocytes |
| MCQ 3 | d β Type IV |
| MCQ 4 | c β OPV |
| MCQ 5 | c β Adrenaline |
| MCQ 6 | b β Secretions |
| MCQ 7 | c β BCG |
| MCQ 8 | c β Discard vaccine |
| MCQ 9 | c β Type III |
| MCQ 10 | c β 5 diseases |
π FINAL 1-PAGE QUICK REVISION SUMMARY
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
β IMMUNITY, HYPERSENSITIVITY & IMMUNIZATION β QUICK REVISION β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β IMMUNITY β
β Innate = fast, non-specific, no memory (skin, phagocytes, NK cells) β
β Adaptive = slow, specific, has memory (B cellsβantibodies; T cells) β
β Active (own antibody, long-lasting) vs Passive (ready-made, short) β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β IMMUNOGLOBULINS (GAMED) β
β IgG = most abundant, crosses placenta β
β IgA = secretions (saliva, milk, tears) β
β IgM = first in primary response, pentamer β
β IgE = allergy/anaphylaxis (binds mast cells) β
β IgD = B-cell surface receptor β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β HYPERSENSITIVITY (ACID) β
β Type I = IgE + mast cells = Anaphylaxis (<30 min) [Penicillin, pollen] β
β Type II = IgG/IgM + complement = Cytotoxic [ABO mismatch, MG] β
β Type III = Immune complexes = Tissue damage [SLE, serum sickness] β
β Type IV = T cells = Delayed 48-72 hrs [Mantoux, contact dermatitis] β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β SEROLOGICAL TESTS β
β Widal=Typhoid | VDRL=Syphilis | ELISA=HIV/HepB | Western Blot=HIV confirmβ
β Mantoux = TB | ANA = SLE | Coombs = Hemolytic anemia β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β VACCINES β
β Live attenuated: BCG, OPV, MMR, Measles (strong, long immunity) β
β Killed: IPV, DPT-whole cell, Hepatitis A (multiple doses needed) β
β Toxoid: DPT, TT (against bacterial toxin) β
β Subunit/Recombinant: HepB, HPV, Pneumococcal, Acellular Pertussis β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β COLD CHAIN IMPORTANT FACTS β
β Heat-sensitive: OPV, BCG, Measles, MMR (store in freezer) β
β Freeze-sensitive: DPT, TT, HepB, IPV, Pentavalent (store +2 to +8Β°C) β
β VVM: inner square LIGHTER = usable β
| SAME/DARKER = discard β β
β Reconstituted BCG/Measles/MMR: use within 4-6 hours β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β NATIONAL IMMUNIZATION SCHEDULE KEY POINTS β
β Birth: BCG (ID), OPV-0 (oral), HepB-0 (IM) β
β 6, 10, 14 weeks: OPV, Pentavalent, Rotavirus (+PCV & fIPV at 6 & 14 wk)β
β 9-12 months: MR-1, PCV booster, Vit A β
β 16-24 months: DPT B1, OPV B, MR-2, Vit A β
β 5-6 years: DPT Booster-2 | 10 & 16 years: Td β
β Pregnant women: TT/Td-1 + TT/Td-2 (4 weeks apart) β neonatal tetanus β
β βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ£
β ANAPHYLAXIS MANAGEMENT β
β FIRST β ADRENALINE 0.5 mg IM (1:1000) outer thigh β
β Then: Oβ, IV fluids, Chlorphenamine, Hydrocortisone β
β Observe 30 min post-vaccination; 6 hrs after anaphylaxis (biphasic) β
ββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Sources: Cellular and Molecular Immunology (Abbas & Lichtman); Janeway's Immunobiology 10e; Robbins & Kumar Basic Pathology; Roitt's Essential Immunology; WHO Immunization Handbook; India UIP Schedule (2024)